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In the present study, we investigated the microenvironment of tumor-draining lymph nodes of cervical cancer patients, by comprehensive flow cytometry-based phenotyping and enumeration of immune-cell subsets in tumor-negative (LN-, n = 20) versus tumor-positive lymph nodes (LN+, n = 8), and by the study of cytokine release profiles (n = 4 for both LN-and LN+).
We found significantly lower CD4 + and higher CD8 + T-cell frequencies in LN+ samples, accompanied by increased surface levels of activation (HLA-DR and ICOS) and inhibitory markers (PD-1 and CTLA-4). Furthermore, in LN+ we found increased rates of a potentially regulatory antigen-presenting cell (APC) subset (CD11c hi CD14 + PD-L1 + ) and of myeloid-derived suppressor cell (MDSC) subsets, which in the case of the former correlated significantly with elevated frequencies of FoxP3 + Tregs. After in vitro stimulation with different TLR ligands (PGN; Poly-IC; R848), we observed higher production levels of IL-6, IL-10 and TNFα but lower levels of IFNγ in LN+.
We conclude that, despite increased T-cell differentiation and activation, a striking switch to a profound immune suppressive microenvironment in LN+ of cervical cancer patients will enable immune escape. Our data point to the CD14 + PD-L1 + APC/Treg axis as a particularly attractive and relevant therapeutic target to specifically tackle microenvironmental immune suppression and thus enhance the efficacy of immunotherapy in patients with metastasized cervical cancer. 
